Get an alert when IPA TALENT GROUP LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£1.8M

+63.7% vs 2023

Net assets

£4.3M

-26.7% vs 2023

Employees

66

-41.6% vs 2023

Profit before tax

-£1.3M

-860.6% vs 2023

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

5-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31

Metric Trend 2019-12-312020-12-312021-12-312023-12-312024-12-31 Δ vs prior
Turnover £28,306,560£18,116,965 -36%
Operating profit -£47,210-£1,313,765 -2,682.8%
Profit before tax -£135,412-£1,300,767 -860.6%
Net profit -£332,486-£1,306,162 -292.8%
Cash £1,111,115£1,818,741 +63.7%
Total assets less current liabilities £101,000£5,794,685£4,250,209 -26.7%
Net assets £5,794,685£4,250,209 -26.7%
Equity £5,812,685£4,250,209 -26.9%
Average employees 570011366 -41.6%
Wages £0£0£8,018,938£5,177,173 -35.4%
Directors' remuneration £83,286£24,000 -71.2%

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2019-12-312020-12-312021-12-312023-12-312024-12-31
Operating margin -0.2%-7.3%
Net margin -1.2%-7.2%
Return on capital employed -0.8%-30.9%
Current ratio 2.85x7.95x
Interest cover -0.54x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. IPA TALENT GROUP LIMITED 2026-02-10 → present
  2. I-PHARM CONSULTING GROUP LIMITED 2017-09-29 → 2026-02-10

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Hartley Fowler LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have reviewed the group's business plan, post year end performance and future forecast, and have confidence that the company has adequate resources to continue in operational existence for the foreseeable future.”

Group structure

  1. IPA TALENT GROUP LIMITED · parent
    1. I-Pharm Consulting Inc. 85% · USA · Recruitment Services
    2. I-Pharm Consulting International Limited 100% · United Kingdom · Dormant
    3. I-Pharm Consulting Australia PTY 100% · Australia · Recruitment Services
    4. I-Pharm Consulting GmbH 100% · Germany · Recruitment Services
    5. I-Pharm Consulting PTE Ltd 100% · Singapore · Recruitment Services

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 3 resigned

Name Role Appointed Born Nationality
LAMPORT-WENT, Steven James Secretary 2017-09-29
AL-TARAFI, Issam Adil Director 2017-09-29 May 1975 British
LAMPORT-WENT, Steven James Director 2017-09-29 Apr 1964 British
MCANANEY, Stephen Peter Director 2020-02-26 Jun 1979 British,Irish
Show 3 resigned officers
Name Role Appointed Resigned
LYNAM, Colin John Director 2020-02-26 2025-01-31
LYNAM, Colin John Director 2017-09-29 2018-02-21
MCANANEY, Stephen Peter Director 2017-09-29 2018-02-21

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
I-Pharm Trustees Limited Corporate entity Shares 75–100% (as trust), Voting 75–100% (as trust), Appoints directors (as trust), Significant influence (as trust) 2025-11-21 Active
Mr Stephen Peter Mcananey Individual Shares 25–50%, Voting 25–50% 2020-02-26 Ceased 2025-11-21
Mr Issam Adil Al-Tarafi Individual Shares 25–50%, Voting 25–50% 2017-09-29 Ceased 2022-04-05
Mr Steven James Lamport-Went Individual Shares 25–50%, Voting 25–50% 2017-09-29 Ceased 2022-04-05

Filing timeline

Last 20 of 76 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2026-02-10 CERTNM Certificate change of name company PDF
  • 2025-12-02 RESOLUTIONS Resolution
  • 2025-12-02 MA Memorandum articles
Date Type Category Description
2026-02-10 CERTNM change-of-name Certificate change of name company PDF
2026-02-03 CS01 confirmation-statement Confirmation statement with updates PDF
2025-12-02 RESOLUTIONS resolution Resolution
2025-12-02 MA incorporation Memorandum articles
2025-11-28 SH08 capital Capital name of class of shares
2025-11-28 SH10 capital Capital variation of rights attached to shares
2025-11-27 SH01 capital Capital allotment shares PDF
2025-11-27 SH01 capital Capital allotment shares PDF
2025-11-27 SH01 capital Capital allotment shares PDF
2025-11-27 SH01 capital Capital allotment shares PDF
2025-11-27 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-11-27 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2025-11-27 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-09-30 AA accounts Accounts with accounts type group PDF
2025-09-16 CH01 officers Change person director company with change date PDF
2025-09-16 CH01 officers Change person director company with change date PDF
2025-09-16 CH03 officers Change person secretary company with change date PDF
2025-03-03 SH03 capital Capital return purchase own shares
2025-02-19 CS01 confirmation-statement Confirmation statement with updates PDF
2025-02-11 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
17

last 12 months

Capital events
7

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page